Concurrent Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Concurrent Investment Advisors's AMGN Position: Q2 2026 in Review
Concurrent Investment Advisors increased its Amgen (AMGN) stake by 20% in Q2 2026, buying an estimated $2.94M and bringing the position to 51,650 shares worth $18.7M. The position accounts for 0.16% of the portfolio, ranked #134.
Concurrent Investment Advisors first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,530 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Concurrent Investment Advisors held 51,650 shares of Amgen worth $18.7M as of Q2 2026.
- Concurrent Investment Advisors bought 8,590 Amgen shares in Q2 2026, an estimated $2.94M.
- Amgen made up 0.16% of Concurrent Investment Advisors's portfolio in Q2 2026, its #134 holding.
- Concurrent Investment Advisors first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 1,530 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.